AbbVie completes acquisition of Allergan

AbbVie, the U.S. biopharmaceutical group, has completed the acquisition of Allergan, an Irish-domiciled pharmaceutical company, following receipt of regulatory approval from all government authorities required by the transaction agreement.

Keep reading this article by becoming a member


Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.